Connection

David Cachia to Middle Aged

Back to Details
This is a "connection" page, showing publications David Cachia has written about Middle Aged.
David Cachia
Connection Strength
0.431
Middle Aged
  1. Ganoderic acid A/DM-induced NDRG2 over-expression suppresses high-grade meningioma growth. Clin Transl Oncol. 2020 Jul; 22(7):1138-1145.
    View in: PubMed
    Score: 0.050
  2. Radiographic patterns of progression with associated outcomes after bevacizumab therapy in glioblastoma patients. J Neurooncol. 2017 Oct; 135(1):75-81.
    View in: PubMed
    Score: 0.043
  3. Primary and secondary gliosarcomas: clinical, molecular and survival characteristics. J Neurooncol. 2015 Nov; 125(2):401-10.
    View in: PubMed
    Score: 0.038
  4. Myelopathy following intrathecal chemotherapy in adults: a single institution experience. J Neurooncol. 2015 Apr; 122(2):391-8.
    View in: PubMed
    Score: 0.036
  5. A case of early-onset rapidly progressive dementia. JAMA Neurol. 2014 Nov; 71(11):1445-9.
    View in: PubMed
    Score: 0.035
  6. Drug-induced thrombocytopenia secondary to natalizumab treatment. BMJ Case Rep. 2014 May 30; 2014.
    View in: PubMed
    Score: 0.034
  7. Brachial amyotrophic diplegia in the setting of complete HIV viral load suppression. BMJ Case Rep. 2012 Dec 06; 2012.
    View in: PubMed
    Score: 0.031
  8. Widely metastatic meningioma. Arch Neurol. 2012 Oct; 69(10):1372-3.
    View in: PubMed
    Score: 0.031
  9. Seizures in Patients With Metastatic Brain Tumors: Prevalence, Clinical Characteristics, and Features on EEG. J Clin Neurophysiol. 2021 Mar 01; 38(2):143-148.
    View in: PubMed
    Score: 0.014
  10. Effect of Vocimagene Amiretrorepvec in Combination With Flucytosine vs Standard of Care on Survival Following Tumor Resection in Patients With Recurrent High-Grade Glioma: A Randomized Clinical Trial. JAMA Oncol. 2020 12 01; 6(12):1939-1946.
    View in: PubMed
    Score: 0.014
  11. Clinical characteristics, EEG findings and implications of status epilepticus in patients with brain metastases. J Neurol Sci. 2019 Dec 15; 407:116538.
    View in: PubMed
    Score: 0.012
  12. Clinical trial participation of patients with glioblastoma at The University of Texas MD Anderson Cancer Center. Eur J Cancer. 2019 05; 112:83-93.
    View in: PubMed
    Score: 0.012
  13. Seizures in patents with primary central nervous system lymphoma: Prevalence and associated features. J Neurol Sci. 2019 May 15; 400:34-38.
    View in: PubMed
    Score: 0.012
  14. The molecular landscape of glioma in patients with Neurofibromatosis 1. Nat Med. 2019 01; 25(1):176-187.
    View in: PubMed
    Score: 0.012
  15. Ependymomas arising outside of the central nervous system: A case series and literature review. J Clin Neurosci. 2018 Jan; 47:202-207.
    View in: PubMed
    Score: 0.011
  16. Radiotherapy with concurrent temozolomide for the management of extraneural metastases in pituitary carcinoma. Pituitary. 2016 Aug; 19(4):415-21.
    View in: PubMed
    Score: 0.010
  17. Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma. J Neurooncol. 2016 08; 129(1):147-54.
    View in: PubMed
    Score: 0.010
  18. Severe peripheral neuropathy following carfilzomib, rituximab, and dexamethasone for initial treatment of Waldenstr?m's macroglobulinemia. Ann Hematol. 2016 Jan; 95(2):347-8.
    View in: PubMed
    Score: 0.009
  19. Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution. J Neurooncol. 2014 Dec; 120(3):597-605.
    View in: PubMed
    Score: 0.009
  20. Peripheral neuropathy after hair dye exposure: a case report. J Clin Neuromuscul Dis. 2014 Jun; 15(4):161-3.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.